Learning Study: Improving Vision in Adults With Macular Degeneration
Improving Vision in Adults With Macular Degeneration, Study 2: The Effect of Concurrent Perceptual Learning and Brain Stimulation
1 other identifier
interventional
30
2 countries
2
Brief Summary
The purpose of this study is to test whether a kind of brain stimulation called anodal transcranial direct current stimulation (a-tDCS) can be combined with perceptual learning to improve the ability of people with age-related macular degeneration (AMD) or juvenile macular degeneration (JMD) to read words presented to them on a computer screen better than if perceptual learning alone were used. In addition, secondary measures of visual acuity will also be examined to determine whether brain stimulation can allow patients to resolve finer details of an image. The proposed treatment is the application of a-tDCS onto the participant's head, with brain stimulation aimed at Primary Visual Cortex toward the occipital pole, while patients undergo six separate sessions of training. The investigators will test the ability of participants to read words before the start of the training sessions (pre test) and after the completion of all training sessions (post test). This is a between-subjects design, and half of the participants will receive true stimulation, and the other half will receive sham stimulation. The difference between the pre and post tests when receiving active stimulation will be compared to the difference when receiving sham stimulation, because the sham stimulation is not expected to influence reading beyond a placebo. The aim of the study is to examine the potential of concurrent brain stimulation and perceptual learning as an effective treatment for macular degeneration that may be used in conjunction with more traditional eye-based interventions. The investigators hypothesize that the brain stimulation will enable higher performance in the reading task after and secondary measures after perceptual training due to an increase in the cortical excitability of the stimulated brain cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2021
CompletedStudy Start
First participant enrolled
February 13, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 22, 2026
May 1, 2025
5.8 years
February 13, 2021
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training.
Behavioral Measure - Participants will verbally read words presented on a computer. A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated. The maximum reading speed and smallest text size will be measured before and after training. The outcome measures are the change in these reading measurements from pre test to post test.
The pre test and post test will take roughly 1 hour to complete, and they will be roughly 4-7 weeks apart.
Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training
Behavioral Measure - Participants will verbally read words presented on a computer. A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated. The maximum reading speed and smallest text size will be measured before and after training. The outcome measures are the change in these reading measurements from pre test to the 30 day follow up.
The test will take roughly 1 hour to complete, and they will be roughly 7-10 weeks apart.
Secondary Outcomes (8)
Change in Uncrowded Visual Acuity before and just after training
The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 4-7 weeks apart.
Change in Uncrowded Visual Acuity before and 30 days after training
The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 7 to 10 weeks apart.
Change in Crowded Visual Acuity before and just after training
The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
Change in Crowded Visual Acuity before and 30 days after training
The tests will take roughly 5 minutes to complete, and they will be roughly 7 - 10 weeks apart.
Change in Contrast Sensitivity before and just after training
The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart.
- +3 more secondary outcomes
Study Arms (2)
Active + Training
ACTIVE COMPARATORParticipants in this arm will be exposed to active stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
Sham + Training
SHAM COMPARATORParticipants in this arm will be exposed to sham stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
Interventions
a weak electric current is applied to the head through electrodes to affect the cortical excitability of the targeted cells in the brain.
The tDCS machine will be used as in active stimulation, except the electrical current will not be applied.
Eligibility Criteria
You may qualify if:
- Diagnosis of AMD (age 60+) or JMD (current age 18+).
- Visual acuity (VA); between 6/9-6/96 in the better eye
- Best-corrected near visual acuity of 4.0M at 40 cm or better in the better eye
- Stable vision in previous 3 months (patient report)
- Central vision loss
You may not qualify if:
- Diagnosed dementia.
- Not fluent in reading English (Waterloo) or Chinese characters (Hong Kong).
- Any ocular surgery (including anti-vegF injections) within the duration of the study, except for: A. Chronic and continuous injections for at least 1 year. B. Injections stopped at least 2 months before participation. C. Injections in the untested eye
- Ocular pathology other than JMD or AMD that can significantly reduce central vision. Example: mild cataract of grade 2 or below is acceptable
- Severe hearing impairment.
- Contraindications for brain stimulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Waterloolead
- The Hong Kong Polytechnic Universitycollaborator
Study Sites (2)
University of Waterloo
Waterloo, Ontario, N2L 3G1, Canada
The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Thompson, PhD
University of Waterloo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The participant and the researcher will be blind to which group any given participant is assigned to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor; Associate Director for Research
Study Record Dates
First Submitted
February 13, 2021
First Posted
February 21, 2021
Study Start
February 13, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 22, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- IDP will be available upon a publication, and no more than 9 months after the publication.
- Access Criteria
- IDP will be shared to researchers who provide a methodologically sound proposal.
IDP that underlie results in a publication will be available after deidentification upon reasonable request to the research team.